Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our conference call intimation dated June 13, 2024, the audio recording of the conference call for acquisition of a majority stake in Sapala Organics held on Wednesday, June 19, 2024, has been uploaded on the Company''s website
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to the proposed merger and the business outlook conference call intimation dated February 29, 2024, the audio recording of the conference call held on Tuesday, March 05, 2024.
Conference Call with Suven Pharmaceuticals Management and Analysts to discuss the merger with Cohance Lifesciences and the business outlook for the combined entity. Listen to the full earnings transcript. Management in attendance: Annaswamy Vaidheesh, Dr. V Prasada Raju, and senior team.
